Minerva Surgical, Inc.
UTRS
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 51.69M | 52.32M | 51.89M | 50.29M | 50.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.69M | 52.32M | 51.89M | 50.29M | 50.14M |
| Cost of Revenue | 23.69M | 23.72M | 23.05M | 23.05M | 22.44M |
| Gross Profit | 28.01M | 28.60M | 28.84M | 27.24M | 27.70M |
| SG&A Expenses | 56.15M | 61.11M | 62.74M | 61.79M | 59.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 85.95M | 90.98M | 91.74M | 90.29M | 86.94M |
| Operating Income | -34.26M | -38.67M | -39.85M | -39.99M | -36.81M |
| Income Before Tax | -33.40M | -37.55M | -34.52M | -34.10M | -17.05M |
| Income Tax Expenses | 53.00K | 50.00K | 11.00K | 11.00K | 9.00K |
| Earnings from Continuing Operations | -33.45 | -37.60 | -34.53 | -34.11 | -17.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.45M | -37.60M | -34.53M | -34.11M | -17.06M |
| EBIT | -34.26M | -38.67M | -39.85M | -39.99M | -36.81M |
| EBITDA | -25.56M | -28.73M | -29.20M | -29.19M | -26.08M |
| EPS Basic | -8.36 | -15.48 | -18.43 | -23.75 | -9.52 |
| Normalized Basic EPS | -7.33 | -11.78 | -15.35 | -18.74 | -5.37 |
| EPS Diluted | -8.36 | -15.48 | -18.43 | -23.75 | -9.52 |
| Normalized Diluted EPS | -7.33 | -11.78 | -15.35 | -18.74 | -5.37 |
| Average Basic Shares Outstanding | 24.03M | 16.59M | 9.16M | 5.76M | 5.36M |
| Average Diluted Shares Outstanding | 24.03M | 16.59M | 9.16M | 5.76M | 5.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
